CN104940631B - A kind of ointment and preparation method thereof - Google Patents
A kind of ointment and preparation method thereof Download PDFInfo
- Publication number
- CN104940631B CN104940631B CN201510390328.3A CN201510390328A CN104940631B CN 104940631 B CN104940631 B CN 104940631B CN 201510390328 A CN201510390328 A CN 201510390328A CN 104940631 B CN104940631 B CN 104940631B
- Authority
- CN
- China
- Prior art keywords
- ointment
- prepared
- difference
- vegetable oil
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses a kind of preparation methods of ointment, include the following steps：Comminuted solids raw material, the solid material include Radix Astragali, the Asian puccoon of 8-12%, the polygonum cuspidate of 8-12%, the bletilla striata of 4-6%, the root of Dahurain angelica of 4-6%, the cape jasmine of 4-6% and the Radix Angelicae Sinensis of 4-6% for accounting for ointment gross mass 8-12% to be prepared；Solid material through crushing is uniformly mixed with the vegetable oil for accounting for ointment gross mass 40-60% to be prepared, obtains ointment.The present invention also provides the formulas of above-mentioned ointment.Ointment provided by technical solution of the present invention has anti-inflammation hemostasia, analgesic myogenic, the good effects quickly to heal for promoting the surface of a wound in the outer used time；Can be used for burning, burn and scald I, II degree, wound and to postoperative wound disunion and scar hyperplasia prevention have outstanding effect, pigment deposition at scar can be effectively prevent.
Description
Technical field
The present invention relates to pharmaceutical field, in particular to a kind of ointment and preparation method thereof.
Background technique
It is common based on myogenic product in the Chinese medicine or Chinese patent drug product in externally applied drug handled for burn and scald mouth, it treats
Effect is had nothing in common with each other.And in biopharmaceutical products for burn and scald mouth processing externally applied drug in then with comprising growth factor be main machine
Reason, this is also the product that scar the most commonly used in current Department of B urn and surgery prevents and treats.Daily hospital handles burns
People allows skin to grow naturally on this basis usually using debridement anti-inflammatory as principle, but when the burn patient for encountering large area
When, unsound due to nutrition situation and body allomeric function, usual surface of a wound restoration ecosystem speed is slow, this will give patient
Very big physiology and psychological pain are brought, the result for the treatment of is often the scar contracture of large area, it is difficult to reach satisfactory
Therapeutic effect.
Summary of the invention
Based on this, it is desirable to provide one kind handles and had for burn and scald mouth anti-inflammation hemostasia, hemostasia and promoting granulation, promotes the surface of a wound fast
The drug of speed healing effect.
To achieve the above object, the preparation method for inventor providing a kind of ointment, includes the following steps：
Comminuted solids raw material, the solid material include Radix Astragali, the 8-12% for accounting for ointment gross mass 8-12% to be prepared
Asian puccoon, the polygonum cuspidate of 8-12%, the bletilla striata of 4-6%, the root of Dahurain angelica of 4-6%, the cape jasmine of 4-6% and 4-6% Radix Angelicae Sinensis；
Solid material through crushing is uniformly mixed with the vegetable oil for accounting for ointment gross mass 40-60% to be prepared, obtains medicine
Cream.
Further, in the preparation method of the ointment, the solid material includes accounting for ointment gross mass 9- to be prepared
11% Radix Astragali, the Asian puccoon of 9-11%, the polygonum cuspidate of 9-11%, the bletilla striata of 4.5-5.5%, the root of Dahurain angelica of 4.5-5.5%, 4.5-
5.5% cape jasmine and the Radix Angelicae Sinensis of 4.5-5.5%；And
Vegetable oil used accounts for ointment gross mass 45-65% to be prepared.
Further, in the preparation method of the ointment, the vegetable oil includes sesame oil, olive oil, tea oil, peanut
Oil, soya-bean oil, linseed oil, castor oil or rape seed oil.
Further, in the preparation method of the ointment, the vegetable oil is tea oil.
Further, in the preparation method of the ointment, the vegetable oil passes through a pre-treatment step, the pretreatment
Step specifically includes：
Vegetable oil is heated to boiling, is then cooled to room temperature.
Further, in the preparation method of the ointment, solid material is crushed to particle ruler when comminuted solids raw material
Very little 10 microns or less.
Inventor additionally provides a kind of ointment simultaneously, is the Radix Astragali of 8-12%, the Asian puccoon of 8-12%, 8- including mass fraction
12% polygonum cuspidate, the bletilla striata of 4-6%, the root of Dahurain angelica of 4-6%, the cape jasmine of 4-6%, the Radix Angelicae Sinensis of 4-6% and the plant of 45-65%
Oil.
It further, is the Radix Astragali of 9-11%, the Asian puccoon of 9-11%, 9-11% including mass fraction in the ointment
Polygonum cuspidate, the bletilla striata of 4.5-5.5%, the root of Dahurain angelica of 4.5-5.5%, the cape jasmine of 4.5-5.5%, 4.5-5.5% Radix Angelicae Sinensis and 45-
65% vegetable oil.
Further, in the ointment, the vegetable oil includes sesame oil, olive oil, tea oil, peanut oil, soya-bean oil, Asia
Sesame oil, castor oil or rape seed oil.
Further, in the ointment, impurity content is lower than 10% in the vegetable oil.
It is different from the prior art, ointment provided by technical solution of the present invention has anti-inflammation hemostasia, analgesic life in the outer used time
Flesh, the good effects quickly to heal for promoting the surface of a wound；It can be used for burning, burn and scald I, II degree, wound and postoperative wound is not cured
It closes and scar hyperplasia prevention has outstanding effect, pigment deposition at scar can be effectively prevent.
Specific embodiment
In order to describe the technical content, the structural feature, the achieved object and the effect of this invention in detail, below in conjunction with embodiment
It is explained in detail.
1st embodiment
Present embodiments provide for a kind of preparation methods of ointment, include the following steps：
S1, comminuted solids raw material to grain diameter are 10 microns；
S2, the solid material through crushing is uniformly mixed with tea oil, obtains ointment.
Wherein, solid material described in step S1 include the Radix Astragali for accounting for ointment gross mass 10% to be prepared, 10% Asian puccoon, 10
Polygonum cuspidate, 5% bletilla striata, 5% root of Dahurain angelica, 5% cape jasmine and 5%% Radix Angelicae Sinensis；
Tea oil described in step S2 accounts for the 50% of ointment gross mass to be prepared.
2nd embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Astragali accounts for be prepared in solid material described in step S1
Ointment gross mass 8%；
Tea oil described in step S2 accounts for the 52% of ointment gross mass to be prepared.
3rd embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Astragali accounts for be prepared in solid material described in step S1
Ointment gross mass 12%；
Tea oil described in step S2 accounts for the 48% of ointment gross mass to be prepared.
4th embodiment
Present embodiment and the 1st embodiment the difference is that, Asian puccoon accounts for be prepared in solid material described in step S1
Ointment gross mass 8%；
Tea oil described in step S2 accounts for the 52% of ointment gross mass to be prepared.
5th embodiment
Present embodiment and the 1st embodiment the difference is that, Asian puccoon accounts for be prepared in solid material described in step S1
Ointment gross mass 12%；
Tea oil described in step S2 accounts for the 48% of ointment gross mass to be prepared.
6th embodiment
Present embodiment and the 1st embodiment the difference is that, polygonum cuspidate accounts for be prepared in solid material described in step S1
Ointment gross mass 8%；
Tea oil described in step S2 accounts for the 52% of ointment gross mass to be prepared.
7th embodiment
Present embodiment and the 1st embodiment the difference is that, polygonum cuspidate accounts for be prepared in solid material described in step S1
Ointment gross mass 12%；
Tea oil described in step S2 accounts for the 48% of ointment gross mass to be prepared.
8th embodiment
Present embodiment and the 1st embodiment the difference is that, the bletilla striata accounts for be prepared in solid material described in step S1
Ointment gross mass 4%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
9th embodiment
Present embodiment and the 1st embodiment the difference is that, the bletilla striata accounts for be prepared in solid material described in step S1
Ointment gross mass 6%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
10th embodiment
Present embodiment and the 1st embodiment the difference is that, the root of Dahurain angelica accounts for be prepared in solid material described in step S1
Ointment gross mass 4%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
11st embodiment
Present embodiment and the 1st embodiment the difference is that, the root of Dahurain angelica accounts for be prepared in solid material described in step S1
Ointment gross mass 6%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
12nd embodiment
Present embodiment and the 1st embodiment the difference is that, cape jasmine accounts for be prepared in solid material described in step S1
Ointment gross mass 4%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
13rd embodiment
Present embodiment and the 1st embodiment the difference is that, cape jasmine accounts for be prepared in solid material described in step S1
Ointment gross mass 6%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
14th embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Angelicae Sinensis accounts for be prepared in solid material described in step S1
Ointment gross mass 4%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
15th embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Angelicae Sinensis accounts for be prepared in solid material described in step S1
Ointment gross mass 6%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
16th embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Astragali accounts for be prepared in solid material described in step S1
Ointment gross mass 9%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
17th embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Astragali accounts for be prepared in solid material described in step S1
Ointment gross mass 11%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
18th embodiment
Present embodiment and the 1st embodiment the difference is that, Asian puccoon accounts for be prepared in solid material described in step S1
Ointment gross mass 9%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
19th embodiment
Present embodiment and the 1st embodiment the difference is that, Asian puccoon accounts for be prepared in solid material described in step S1
Ointment gross mass 11%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
20th embodiment
Present embodiment and the 1st embodiment the difference is that, polygonum cuspidate accounts for be prepared in solid material described in step S1
Ointment gross mass 9%；
Tea oil described in step S2 accounts for the 51% of ointment gross mass to be prepared.
21st embodiment
Present embodiment and the 1st embodiment the difference is that, polygonum cuspidate accounts for be prepared in solid material described in step S1
Ointment gross mass 11%；
Tea oil described in step S2 accounts for the 49% of ointment gross mass to be prepared.
22nd embodiment
Present embodiment and the 1st embodiment the difference is that, the bletilla striata accounts for be prepared in solid material described in step S1
Ointment gross mass 4.5%；
Tea oil described in step S2 accounts for the 50.5% of ointment gross mass to be prepared.
23rd embodiment
Present embodiment and the 1st embodiment the difference is that, the bletilla striata accounts for be prepared in solid material described in step S1
Ointment gross mass 5.5%；
Tea oil described in step S2 accounts for the 49.5% of ointment gross mass to be prepared.
24th embodiment
Present embodiment and the 1st embodiment the difference is that, the root of Dahurain angelica accounts for be prepared in solid material described in step S1
Ointment gross mass 4.5%；
Tea oil described in step S2 accounts for the 50.5% of ointment gross mass to be prepared.
25th embodiment
Present embodiment and the 1st embodiment the difference is that, the root of Dahurain angelica accounts for be prepared in solid material described in step S1
Ointment gross mass 5.5%；
Tea oil described in step S2 accounts for the 49.5% of ointment gross mass to be prepared.
26th embodiment
Present embodiment and the 1st embodiment the difference is that, cape jasmine accounts for be prepared in solid material described in step S1
Ointment gross mass 4.5%；
Tea oil described in step S2 accounts for the 50.5% of ointment gross mass to be prepared.
27th embodiment
Present embodiment and the 1st embodiment the difference is that, cape jasmine accounts for be prepared in solid material described in step S1
Ointment gross mass 5.5%；
Tea oil described in step S2 accounts for the 49.5% of ointment gross mass to be prepared.
28th embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Angelicae Sinensis accounts for be prepared in solid material described in step S1
Ointment gross mass 4.5%；
Tea oil described in step S2 accounts for the 50.5% of ointment gross mass to be prepared.
29th embodiment
Present embodiment and the 1st embodiment the difference is that, Radix Angelicae Sinensis accounts for be prepared in solid material described in step S1
Ointment gross mass 5.5%；
Tea oil described in step S2 accounts for the 49.5% of ointment gross mass to be prepared.
In the preparation method that can be seen that traditional Chinese medicinal ointment of the present invention to the 29th embodiment from the 2nd embodiment, the raw material packet of ointment
Solid material and tea oil two parts are included, after the dosage (ratio) that solid material has been determined, the amount of tea oil also determines therewith.
30th embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with sesame oil.
31st embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with olive oil.
32nd embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with peanut oil.
33rd embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with soya-bean oil.
34th embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with linseed oil.
35th embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with castor oil.
36th embodiment
Present embodiment and the 1st embodiment the difference is that, tea oil described in step S2 is substituted with rape seed oil.
It can be seen that from the 30th to 36 embodiment, oils raw material used in step S2 is vegetable oil.
37th embodiment
Present embodiment and the 1st embodiment the difference is that, (or the other embodiments of tea oil used in step S2
Used in other plant oil) pass through a pre-treatment step, the pre-treatment step specifically includes：
Vegetable oil is heated to boiling, and keeps fluidized state 5-15 minutes；It then cools to room temperature.
38th embodiment
Present embodiment and the 1st embodiment the difference is that, (or the other embodiments of tea oil used in step S2
Used in other plant oil) pass through a pre-treatment step, the pre-treatment step specifically includes：
Vegetable oil is heated to boiling, is then cooled to room temperature.
The pre-treatment step purpose of vegetable oil is to further increase vegetable oil purity described in 37th or 38 embodiments,
Impurity content is reduced, to promote ointment effect.Certainly, other can also be applied to the technology of the present invention side to the process of vegetable oil removal of impurities
Case is to reach same purpose.
39th embodiment
Present embodiment and the 1st embodiment the difference is that, comminuted solids raw material to grain diameter is 8 in step S1
Microns.
40th embodiment
Present embodiment and the 1st embodiment the difference is that, comminuted solids raw material to grain diameter is 5 in step S1
Microns.
41st embodiment
Present embodiments provide for a kind of medical ointment prescriptions, are 10% Radix Astragali, 10% Asian puccoon, 10% including mass fraction
Polygonum cuspidate, 5% bletilla striata, 5% root of Dahurain angelica, 5% cape jasmine, 5% Radix Angelicae Sinensis and 50% tea oil.
Also, impurity content is 10% in tea oil.
42nd embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Astragali mass fraction in medical ointment prescription is 8%, and
Vegetable oil mass fraction is 52%.
43rd embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Astragali mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
44th embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Astragali mass fraction in medical ointment prescription is 12%,
And vegetable oil mass fraction is 48%.
45th embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Astragali mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 51%.
46th embodiment
Present embodiment and the 41st embodiment the difference is that, the Asian puccoon mass fraction in medical ointment prescription is 8%, and
Vegetable oil mass fraction is 52%.
47th embodiment
Present embodiment and the 41st embodiment the difference is that, the Asian puccoon mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
48th embodiment
Present embodiment and the 41st embodiment the difference is that, the Asian puccoon mass fraction in medical ointment prescription is 12%,
And vegetable oil mass fraction is 48%.
49th embodiment
Present embodiment and the 41st embodiment the difference is that, the Asian puccoon mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 51%.
50th embodiment
Present embodiment and the 41st embodiment the difference is that, the polygonum cuspidate mass fraction in medical ointment prescription is 8%, and
Vegetable oil mass fraction is 52%.
51st embodiment
Present embodiment and the 41st embodiment the difference is that, the polygonum cuspidate mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
52nd embodiment
Present embodiment and the 41st embodiment the difference is that, the polygonum cuspidate mass fraction in medical ointment prescription is 12%,
And vegetable oil mass fraction is 48%.
53rd embodiment
Present embodiment and the 41st embodiment the difference is that, the polygonum cuspidate mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 51%.
54th embodiment
Present embodiment and the 41st embodiment the difference is that, the bletilla striata mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
55th embodiment
Present embodiment and the 41st embodiment the difference is that, the bletilla striata mass fraction in medical ointment prescription is 9.5%,
And vegetable oil mass fraction is 50.5%.
56th embodiment
Present embodiment and the 41st embodiment the difference is that, the bletilla striata mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 49%.
57th embodiment
Present embodiment and the 41st embodiment the difference is that, the bletilla striata mass fraction in medical ointment prescription is
10.5%, and vegetable oil mass fraction is 49.5%.
58th embodiment
Present embodiment and the 41st embodiment the difference is that, the root of Dahurain angelica mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
59th embodiment
Present embodiment and the 41st embodiment the difference is that, the root of Dahurain angelica mass fraction in medical ointment prescription is 9.5%,
And vegetable oil mass fraction is 50.5%.
60th embodiment
Present embodiment and the 41st embodiment the difference is that, the root of Dahurain angelica mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 49%.
61st embodiment
Present embodiment and the 41st embodiment the difference is that, the root of Dahurain angelica mass fraction in medical ointment prescription is
10.5%, and vegetable oil mass fraction is 49.5%.
62nd embodiment
Present embodiment and the 41st embodiment the difference is that, the cape jasmine mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
63rd embodiment
Present embodiment and the 41st embodiment the difference is that, the cape jasmine mass fraction in medical ointment prescription is 9.5%,
And vegetable oil mass fraction is 50.5%.
64th embodiment
Present embodiment and the 41st embodiment the difference is that, the cape jasmine mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 49%.
65th embodiment
Present embodiment and the 41st embodiment the difference is that, the cape jasmine mass fraction in medical ointment prescription is
10.5%, and vegetable oil mass fraction is 49.5%.
66th embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Angelicae Sinensis mass fraction in medical ointment prescription is 9%, and
Vegetable oil mass fraction is 51%.
67th embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Angelicae Sinensis mass fraction in medical ointment prescription is 9.5%,
And vegetable oil mass fraction is 50.5%.
68th embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Angelicae Sinensis mass fraction in medical ointment prescription is 11%,
And vegetable oil mass fraction is 49%.
69th embodiment
Present embodiment and the 41st embodiment the difference is that, the Radix Angelicae Sinensis mass fraction in medical ointment prescription is
10.5%, and vegetable oil mass fraction is 49.5%.
70th embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with sesame oil.
71st embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with sesame oil.
72nd embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with olive oil.
73rd embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with peanut oil.
74th embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with soya-bean oil.
75th embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with linseed oil.
76th embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with castor oil.
77th embodiment
Present embodiment and the 41st embodiment the difference is that, tea oil is substituted with rape seed oil.
78th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 9% in vegetable oil.
79th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 8% in vegetable oil.
80th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 7% in vegetable oil.
81st embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 6% in vegetable oil.
82nd embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 6% in vegetable oil.
83rd embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 5% in vegetable oil.
84th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 4% in vegetable oil.
85th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 3% in vegetable oil.
86th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 2% in vegetable oil.
87th embodiment
Present embodiment and the 41st embodiment the difference is that, impurity content is 1% in vegetable oil.
It is prepared with ointment preparation method described in the 1st embodiment (and medical ointment prescription described in the 41st embodiment)
Ointment carries out animal experiment, and 20 deep II degree burn wound Rabbits Models are randomly divided into medication group 10 and control group 10 and are investigated
Wound healing situation leaves rate evaluation curative effect with Wound healing rate (=healing area/primary trauma area) and scar, as a result
It is as follows：
It is prepared with ointment preparation method described in the 1st embodiment (and medical ointment prescription described in the 41st embodiment)
Ointment carry out clinical human's test, under the conditions of own control, investigate its to II degree burn and scald, take (confession) dermatotome, ulcer wound surface,
The clinical efficacy of operative incision, diabetic 80 patients's (there are no restrictions on age or sex) such as postoperative and adverse reaction, as a result see below
Table：
It can be seen that ointment provided by technical solution of the present invention can effectively accelerate to promote wound healings such as burn and scald and big
The big scar that reduces leaves degree.
The above description is only an embodiment of the present invention, is not intended to limit scope of patent protection of the invention, all utilizations
Equivalent structure or equivalent flow shift made by present specification is applied directly or indirectly in other relevant technologies
Field is included within the scope of the present invention.
Claims (2)
1. a kind of preparation method of ointment, which is characterized in that include the following steps：
Comminuted solids raw material, the solid material include the Radix Astragali for accounting for ointment gross mass 10% to be prepared, 10% Asian puccoon, 10%
Polygonum cuspidate, 5% bletilla striata, 5% root of Dahurain angelica, 5% cape jasmine and 5% Radix Angelicae Sinensis；
Solid material through crushing is uniformly mixed with the vegetable oil for accounting for ointment gross mass 50% to be prepared, obtains ointment；
The vegetable oil is tea oil；
The vegetable oil passes through a pre-treatment step, and the pre-treatment step specifically includes：
Vegetable oil is heated to boiling, is then cooled to room temperature；
Solid material is crushed to 10 microns of particle size or less when comminuted solids raw material.
2. it is a kind of promote wound healing ointment, which is characterized in that including mass fraction be 10% Radix Astragali, 10% Asian puccoon,
10% polygonum cuspidate, 5% bletilla striata, 5% root of Dahurain angelica, 5% cape jasmine, 5% Radix Angelicae Sinensis and 50% vegetable oil；The vegetable oil
Middle impurity content is lower than 10%；The vegetable oil is tea oil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510390328.3A CN104940631B (en) | 2015-07-06 | 2015-07-06 | A kind of ointment and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510390328.3A CN104940631B (en) | 2015-07-06 | 2015-07-06 | A kind of ointment and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104940631A CN104940631A (en) | 2015-09-30 |
| CN104940631B true CN104940631B (en) | 2018-11-16 |
Family
ID=54156055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510390328.3A Expired - Fee Related CN104940631B (en) | 2015-07-06 | 2015-07-06 | A kind of ointment and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104940631B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105641442A (en) * | 2016-01-28 | 2016-06-08 | 张月萍 | Medicine for scalds and burns and preparation method thereof |
| CN109771568A (en) * | 2019-02-22 | 2019-05-21 | 南阳南石医院 | A kind of biological agent and preparation method for inhibiting scar and promoting wound healing |
| CN112076285A (en) * | 2020-10-28 | 2020-12-15 | 成都市郫都区人民医院 | External traditional Chinese medicine composition for treating skin diseases, traditional Chinese medicine preparation and preparation method thereof |
| CN112656895A (en) * | 2020-12-15 | 2021-04-16 | 刘坚胜 | Burn and scald rehabilitation liquid and preparation method thereof |
| CN113230332B (en) * | 2021-05-29 | 2022-05-13 | 黄淑珂 | Medicine for treating wound ulceration of diabetic patient and non-healing wound, preparation and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101219190A (en) * | 2007-01-09 | 2008-07-16 | 李保力 | Traditional Chinese medicine preparation and medical ointment for treating empyrosis |
| CN104706772A (en) * | 2013-12-13 | 2015-06-17 | 淄博开发区亚大制药有限责任公司 | Chinese patent medicine for treating burn and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005075755A (en) * | 2003-08-29 | 2005-03-24 | Daikyo Yakuhin Kogyo Kk | Antiphlogistic-sedative plaster and method for producing the same |
-
2015
- 2015-07-06 CN CN201510390328.3A patent/CN104940631B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101219190A (en) * | 2007-01-09 | 2008-07-16 | 李保力 | Traditional Chinese medicine preparation and medical ointment for treating empyrosis |
| CN104706772A (en) * | 2013-12-13 | 2015-06-17 | 淄博开发区亚大制药有限责任公司 | Chinese patent medicine for treating burn and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 复方虎杖烧伤油膏的研制与临床应用;朱勤等;《福建药学杂志》;19941231;第6卷(第1期);第24页 * |
| 烫烧油治疗烫烧伤150例;焦红波;《中医外治杂志》;19961231(第2期);第6页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104940631A (en) | 2015-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104940631B (en) | A kind of ointment and preparation method thereof | |
| CN102091272B (en) | Black plaster product for bone fracture and preparation method thereof | |
| CN108815349A (en) | A kind of anticancer, antitumor Chinese medicine preparation and preparation method thereof | |
| CN105012686B (en) | A kind of pharmaceutical preparation and preparation method thereof for treating Shelled Turtle Trionyx Sinensis stress disease | |
| CN100425169C (en) | Chinese herbal health-caring beverage | |
| CN103285278A (en) | Medicament for preventing and treating ischemic cerebral apoplexy and preparation method thereof | |
| CN1726964A (en) | Chinese materia medica preparation for curing fracture and traumatic injury | |
| CN101698094B (en) | Distillate for treating white vein diseases and preparation method thereof | |
| CN102742828A (en) | Dietetic therapy product for protecting prostate and preparation method thereof | |
| CN105561184A (en) | Medicinal composition for activating blood circulation, dissipating blood stasis, warming meridians and relaxing veins, and preparation method thereof | |
| CN1111045C (en) | Chewing medicine for treating facial paralysis and its preparing process | |
| CN104547474B (en) | A kind of purposes of Chinese medicine preparation in treatment liver-cancer medicine is prepared | |
| CN109223933A (en) | A kind of Chinese medicine external cleaning agent for treating infective wound surface caused by multi-drug resistant bacteria | |
| CN103446460B (en) | Chinese herba preparation for nursing polio sequela and preparation method thereof | |
| CN101904906B (en) | Rhizoma corydalis pain-relieving dripping pill preparation and preparation process thereof | |
| CN108542994B (en) | A pharmaceutical composition for treating lumbago caused by traumatic injury and acute strain, and its preparation method | |
| CN105412322A (en) | Traditional Chinese medicine preparation for treating diabetic peripheral neuropathic pain and preparation method thereof | |
| CN1039089C (en) | Traditional Chinese Medicine preparation for curing hyperplasia of prostate | |
| CN102451444A (en) | Jingtongning recipe and preparation method thereof | |
| CN105963558A (en) | Plant extract for treating fever of children and application thereof | |
| CN117018142A (en) | Bone injury ointment and preparation method thereof | |
| CN101084977A (en) | Traditional Chinese medicinal composition for curing facial paralysis | |
| CN106853193A (en) | It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof | |
| CN104147232A (en) | Traditional Chinese medicinal composition for treating psoriasis, and preparation method thereof | |
| CN104523932A (en) | Traditional Chinese medicine composition for treating hyperactivity of children and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181116 Termination date: 20200706 |